The Trump administration is freezing, delaying and revoking funding for dementia research, setting back discoveries of ...

Older adults living with Type 2 diabetes face more than just blood sugar concerns. New research shows some of the most ...

Research confirms the Lumipulse serum p-tau217 assay's effectiveness in diagnosing Alzheimer's, paving the way for accessible ...

A new study reveals how age, sex, menopause, and genetics influence key blood biomarkers linked to dementia risk.

A new study has found important clues about the roles age, sex, hormonal changes and genetics play in how certain biomarkers ...

Blood biomarkers like tau217, NfL, and GFAP may predict dementia up to 10 years early, but aren't yet reliable for widespread screening, a Karolinska Institutet study finds. A new study published in ...

A new study has found important clues about the roles age, sex, hormonal changes and genetics play in how certain biomarkers for dementia are expressed in the blood, according to a new study.

The New England Family Study, launched in 1959 and now led by a Brown epidemiologist, spans three generations of participants ...

A new scientific breakthrough may soon offer hope for people affected by Alzheimer’s disease. A group of researchers in Spain has developed a drug candidate that could help fight the condition at its ...

A study led by researchers in the University of Florida College of Pharmacy has found that a pair of popular glucose-lowering medications may have protective effects against the development of ...

Individuals with a genetic predisposition to Alzheimer's disease show altered blood levels indicating damaged neuronal contacts as early as 11 years before the expected onset of dementia symptoms.

This story was originally published by CalMatters. Sign up for their newsletters. By Mikhail Zinshteyn, CalMatters A ...